text.skipToContent text.skipToNavigation
医薬品

医薬品

Innovative pharmaceutical ingredients for pharmaceutical synthesis and formulation

医薬品

6アイテムが見つかりました。

フィルター
適用されたフィルターすべてクリア

カテゴリ
アプリケーション
サプライヤー
Sustainable
サンプルリクエスト
要求者の連絡先の詳細
フルネーム
会社
位置
電話番号
仕事用メールアドレス
お届け先の住所

Thank you. Your request has been sent.

Tacrolimus

Tacrolimus is an immunosuppressive drug. It is used after allogeneic organ transplant to lower the risk of organ rejection and also as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis.
Rapamycin (Sirolimus)_e

Rapamycin, also known as sirolimus , is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection and treat a rare lung disease called lymphangioleiomyomatosis. It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants.
Mycophenolate Mofetil

Mycophenolate Mofetil (CellCept) and Mycophenolate Sodium (Myfortic) are immunosuppressant drugs (a class of drugs that reduce the strength of the body's immune system) used in the treatment of several autoimmune diseases.
Mycophenolate Mofetil HCL

Mycophenolate mofetil, also known as MMF or CellCept, is a prodrug of mycophenolic acid and classified as a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). This drug is an immunosuppressant combined with drugs such as Cyclosporine and corticosteroids to prevent organ rejection after hepatic, renal and cardiac transplants.
商品数量を更新しました。